Despite the absence of discernible disparities in glycemic control or underlying diabetic conditions, the baseline serum proinsulin levels were notably higher in the cognitive impairment cohort compared to the normal cognitive function group (as detailed in Table 3). The gene discussed is INS; the disease is Cognitive impairment.